CASI Pharmaceuticals

CASI

Market cap $4.26M

Delisted

CASI was delisted on the 25th of February, 2026.

31 hedge funds and large institutions have $2.56M invested in CASI Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New

Increased

Maintained

Reduced

Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

14% more capital invested

Capital invested by funds: $2.25M → $2.56M (+$318K)

11% more funds holding

Funds holding: 28 → 31 (+3)

Holders

Holders Change

Holders Change %

+10.71%

% of All Funds

0.83%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	Goldman Sachs New York	+$38.1K
2	Renaissance Technologies New York	+$11.2K
3	MC Moors & Cabot Boston, Massachusetts	+$7.76K
4	Royal Bank of Canada Toronto, Ontario, Canada	+$2.51K
5	WJA Williams Jones & Associates New York	+$2.17K